4//SEC Filing
Pomerantz Roger 4
Accession 0000950170-24-076990
CIK 0001061027other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 7:40 PM ET
Size
7.6 KB
Accession
0000950170-24-076990
Insider Transaction Report
Form 4
Pomerantz Roger
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+18,750→ 18,750 totalExercise: $0.57Exp: 2034-06-20→ Common Stock (18,750 underlying) - Award
Stock Option (Right to Buy)
2024-06-20+50,000→ 50,000 totalExercise: $0.57Exp: 2034-06-20→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1/12th of the shares subject to the option shall vest each month following the date of grant, or if earlier 100% of the shares subject to the option shall vest on the date of the Issuer's next annual stockholder meeting, in each case subject to the reporting person remaining a Service Provider (as defined in the 2021 Equity Incentive Plan) through the applicable vesting date.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001614936
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 7:40 PM ET
- Size
- 7.6 KB